Journey Advisory Group’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$731K Sell
1,839
-57
-3% -$24.9K 0.06% 177
2026
Q1
$874K Buy
1,896
+523
+38% +$265K 0.07% 152
2025
Q4
$778K Sell
1,373
-627
-31% -$334K 0.07% 165
2025
Q3
$894K Buy
2,000
+28
+1% +$13.4K 0.07% 159
2025
Q2
$1.07M Buy
1,972
+126
+7% +$65.9K 0.08% 159
2025
Q1
$914K Buy
1,846
+962
+109% +$532K 0.07% 155
2024
Q4
$393K Hold
884
0.05% 171
2024
Q3
$393K Hold
884
0.05% 171
2024
Q2
$393K Buy
884
+101
+13% +$40.2K 0.05% 171
2024
Q1
$312K Sell
783
-237
-23% -$89.6K 0.04% 194
2023
Q4
$344K Buy
1,020
+23
+2% +$6.86K 0.05% 169
2023
Q3
$291K Sell
997
-1
-0.1% -$312 0.04% 178
2023
Q2
$341K Buy
998
+120
+14% +$36.3K 0.05% 171
2023
Q1
$224K Buy
878
+83
+10% +$20.4K 0.04% 220
2022
Q4
$211K Buy
+795
New +$194K 0.05% 213

Other funds holding ISRG

Journey Advisory Group's ISRG Position: Q2 2026 in Review

Journey Advisory Group reduced its Intuitive Surgical (ISRG) stake by 3% in Q2 2026, selling an estimated $24.9K and leaving 1,839 shares worth $731K. The position accounts for 0.06% of the portfolio, ranked #177.

Journey Advisory Group first reported a position in ISRG in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.07M in Q2 2025. 1,546 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Journey Advisory Group held 1,839 shares of Intuitive Surgical worth $731K as of Q2 2026.
  • Journey Advisory Group sold 57 Intuitive Surgical shares in Q2 2026, an estimated $24.9K.
  • Intuitive Surgical made up 0.06% of Journey Advisory Group's portfolio in Q2 2026, its #177 holding.
  • Journey Advisory Group first reported a position in Intuitive Surgical in Q4 2022 and has held it in 15 quarters since.
  • Journey Advisory Group's Intuitive Surgical position peaked at $1.07M in Q2 2025.
  • 1,546 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Journey Advisory Group's 13F filing for Q2 2026, filed 4 Aug 2026.